Total Funding
55
24
Total FundingSeries A raised
Growth Score 55 in past quarter
-1 pts
Heat Score 24 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
24598
Kimia is a drug discovery company applying high throughput precision chemistry in combination.
- Jack Sadowsky: Co-Founder and VP, Discovery Chemistry
- Stig Hansen: Co-Founder, President, and CEOPast Role: Carmot Therapeutics, Co-Founder and CEO
About the Company
KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease.